| polymorphism | factor | odds ratio | pvalue | initial number | replication number | Population | age of cases | shorter lived allele | longer lived allele | study type | reference |
| CYP2D6*3 | CYP2D6 | — | 1.0 | 552 vs 243 | — | French | mean 101 | — | — | Candidate Region/Gene | 9654200 |
| CYP2D6*4 | CYP2D6 | — | 1.0 | 523 vs 252 | — | French | mean 101 | — | — | Candidate Region/Gene | 9654200 |
| GSTM1 deletion | GSTM1 | — | 1.0 | 565 vs 229 | — | French | mean 101 | — | — | Candidate Region/Gene | 9654200 |
| NAT2*5A (C 481 T), NAT2*6A (G 590 A), NAT2*7A (G 857 A), and NAT2*14A (G 191 A) | NAT2 | — | 1.0 | 188 vs 88 | — | French | mean 101 | — | — | Candidate Region/Gene | 9654200 |
| - | PARP1 | — | 1.0 | 239 vs 198 | — | French | >100 | — | — | Candidate Region/Gene | 9587069 |
| apoAIV(360:His) | APOA4 | — | 0.005 | 119 (see notes) vs 264 | — | French | 74.29 ∓ 8.46 | ApoAIV-1_x000D_, by the order of the sentence - I'm assuming it's Glutamine = G | — | Candidate Region/Gene | 9533408 |
| I/D (insertion/deletion) | ACE | — | 0.33 | 560 vs 560 | — | French | centenarians 100th year or beyond, mean age 103.1 | — | — | Candidate Region/Gene | 11280044 |
| E2 / E3 / E4 | APOE | — | 1.2e-08 | 560 vs 560 | — | French | centenarians 100th year or beyond, mean age 103.1 | E4 | — | Candidate Region/Gene | 11280044 |
| rs662 | PON1 | 1.06 | 0.11 | — | — | Danish, Dutch, French, German, Italian, Tatar | >/=80 | — | — | Candidate Region/Gene | 20362697 |
